Ultra Chiron Pharmaceuticals Pvt Ltd
About Ultra Chiron Pharmaceuticals Pvt Ltd
Data last updated:
Ultra Chiron Pharmaceuticals Pvt Ltd is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231CH1993PTC013535. Its GSTIN is 03AAACU4482F1ZK (Punjab). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹29.73 Lakh. It is led by directors including Sanjeev Kumar (Managing Director) and Amrik Singh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 80 Industrial Area Phase II, Chandigarh, India – 160001.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.09 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹7.8 Lakh (net margin 1.3%) and EBITDA of ₹19.69 Lakh (EBITDA margin 3.2%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 8% over five years.
The company is associated with 1 brand: PharmaHopers. As per MCA filings, the company has open charges of ₹11 Lakh on record. Court records list 4 cases involving the company, including 4 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ultra Chiron Pharmaceuticals Pvt Ltd's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 80 Industrial Area Phase II, Chandigarh, India – 160001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ultra Chiron Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ultra Chiron Pharmaceuticals operates one associated brand: PharmaHopers. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| B2B platform connecting pharmaceutical buyers and sellers for franchises and manufacturing. | pharmahopers.com |
Business activity
The main business activities of Ultra Chiron Pharmaceuticals are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ultra Chiron Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Ultra Chiron Pharmaceuticals Pvt Ltd
FY 2025 filings availableUltra Chiron Pharmaceuticals Pvt Ltd reported revenue of ₹6.09 Cr (down 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 25% fall in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ultra Chiron Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Ultra Chiron Pharmaceuticals Pvt Ltd
Ultra Chiron Pharmaceuticals has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mitesh Kumar Also directs: Ultra Chiron Healthcare Private Limited | Director | 24 Feb 2016 | 10 Years 8 Months | Current |
| Sadhu Singh | Director | 12 Mar 1999 | 27 Years 8 Months | Current |
| Rajesh Biswanath Shrivastava Also directs: Quixotic Pharma Private Limited | Director | 16 Aug 2019 | 7 Years 2 Months | Current |
| Sanjeev Kumar Also directs: Quixotic Pharma Private Limited, Zenlabs Ethica Limited, Oasis Pharma and Phytomolecules Private Limited and 3 more | Managing Director | 20 Jul 1993 | 33 Years 3 Months | Current |
| Amrik Singh | Whole-Time Director | 23 Dec 2014 | 11 Years 10 Months | Current |
| Ashok Kumar Mishra Also directs: Quixotic Pharma Private Limited | Additional Director | 06 Mar 2025 | 1 Years 8 Months | Current |
Auditor
Ultra Chiron Pharmaceuticals Pvt Ltd is audited by N KUMAR CHHABRA & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N KUMAR CHHABRA & CO | FY 2024 | 000837N |
Shareholding
The shareholding of Ultra Chiron Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ultra Chiron Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 May 1997 | 90385245 | Indian Overseas Bank | ₹5.5 Lakh | Open | |
| 10 May 1997 | 90369917 | Indian Overseas Bank | ₹5.5 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Ultra Chiron Pharmaceuticals Pvt Ltd has 4 court cases on record: 4 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West Godavari, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Guntur, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
| District court, SAS Nagar, Punjab | Commercial suit | Filed against the company | Disposed |
To see the full case history of Ultra Chiron Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Ultra Chiron Pharmaceuticals Pvt Ltd has 13 MSME Form 1 returns on record between 2019 and 2024, listing 1,000 overdue payments to 45 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 45)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Jasco Paper Products | |||
| Tiwari Pharma Private Limited | |||
| Durba Pharma | |||
| Infinity Laboratories Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Ultra Chiron Pharmaceuticals Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Ultra Chiron Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAACU4482F1ZK | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ultra Chiron Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Ultra Chiron Pharmaceuticals Pvt Ltd has 17 board changes on record since 1993: 8 appointments and 9 cessations. The latest: Ashok Kumar Mishra was appointed as Additional Director on 06 Mar 2025.
10 earlier events are in the company report.
Frequently asked questions
Ultra Chiron Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 1993 (33+ years old) and is registered under CIN U24231CH1993PTC013535.
Ultra Chiron Pharmaceuticals has 6 current directors:
- Sanjeev Kumar - Managing Director
- Amrik Singh - Whole-Time Director
- Mitesh Kumar - Director
- Sadhu Singh - Director
- Rajesh Biswanath Shrivastava - Director
- Ashok Kumar Mishra - Additional Director
The latest financial statements of Ultra Chiron Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ultra Chiron Pharmaceuticals is 03AAACU4482F1ZK, registered in Punjab. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Ultra Chiron Pharmaceuticals is U24231CH1993PTC013535. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ultra Chiron Pharmaceuticals has 4 court cases on record: 4 filed against it. 2 are pending.
Ultra Chiron Pharmaceuticals was incorporated on 20 July 1993, making it 33+ years old. It is registered with the Registrar of Companies, Chandigarh.
Ashok Kumar Mishra was appointed as Additional Director on 06 Mar 2025. Gurmit Singh ceased to be Director on 17 Oct 2024. Sudhakar ceased to be Additional Director on 29 Sep 2023. Ultra Chiron Pharmaceuticals has 17 board changes on record in total.
Ultra Chiron Pharmaceuticals has 13 MSME Form 1 returns on record between 2019 and 2024, listing 1,000 overdue payments to 45 micro and small suppliers. The latest return was filed on 27 Apr 2024.
The registered office of Ultra Chiron Pharmaceuticals is at Plot No 80 Industrial Area Phase II, Chandigarh, India – 160001.
Ultra Chiron Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
